165 related articles for article (PubMed ID: 35945030)
1. Possible Chronic Graft-versus-host Disease in the Central Nervous System Manifesting as Cerebellar Ataxia after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Takahashi K; Katayama T; Ichikawa T; Matsuoka S; Kakinoki Y; Yoneda M; Kimura A; Koyama S; Yahara O
Intern Med; 2023 Mar; 62(5):779-786. PubMed ID: 35945030
[TBL] [Abstract][Full Text] [Related]
2. Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
Shargian-Alon L; Raanani P; Rozovski U; Siegal T; Yust-Katz S; Yeshurun M
Acta Haematol; 2019; 141(1):19-22. PubMed ID: 30439710
[TBL] [Abstract][Full Text] [Related]
3. [Central nervous system involvement of graft versus host disease after allogeneic hematopoietic stem cell transplantation for adult T cell leukemia].
Ide T; Iida K; Katsuya H; Ito H; Aishima S; Hara H
Rinsho Shinkeigaku; 2022 Jan; 62(1):33-38. PubMed ID: 34924471
[TBL] [Abstract][Full Text] [Related]
4. A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
Das J; Gill A; Lo C; Chan-Lam N; Price S; Wharton SB; Jessop H; Sharrack B; Snowden JA
Front Immunol; 2020; 11():668. PubMed ID: 32431694
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
6. Immune Ablation and Stem Cell Rescue in Two Pediatric Patients with Progressive Severe Chronic Graft-Versus-Host Disease.
Kloehn J; Kruchen A; Schütze K; Wustrau K; Schrum J; Müller I
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499733
[TBL] [Abstract][Full Text] [Related]
7. Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Battipaglia G; Labopin M; Hamladji RM; Blaise D; Chevallier P; Brissot E; Gerbitz A; Socié G; Afanasyev B; Ciceri F; Meijer E; Koc Y; Cornelissen JJ; Huynh A; Ozdogu H; Maertens J; Paul F; Labussière-Wallet H; Ruggeri A; Aljurf M; Bazarbachi A; Savani B; Nagler A; Mohty M
Cancer; 2021 Jan; 127(2):209-218. PubMed ID: 33119152
[TBL] [Abstract][Full Text] [Related]
8. Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation.
Eefting M; von dem Borne PA; de Wreede LC; Halkes CJ; Kersting S; Marijt EW; Veelken H; Falkenburg JF
Haematologica; 2014 Apr; 99(4):751-8. PubMed ID: 24241493
[TBL] [Abstract][Full Text] [Related]
9. The black swan: a case of central nervous system graft-versus-host disease.
Butera S; Tavarozzi R; Brunello L; Rivela P; Sofia A; Viero L; Salvio M; Ladetto M; Zallio F
J Basic Clin Physiol Pharmacol; 2023 Nov; 34(6):805-809. PubMed ID: 37843253
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
[TBL] [Abstract][Full Text] [Related]
11. Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Alanazi W; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Al-Shaibani Z; Mattsson J; Michelis FV
Acta Haematol; 2021; 144(1):66-73. PubMed ID: 32428903
[TBL] [Abstract][Full Text] [Related]
12. Ex Vivo CD34
Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
[TBL] [Abstract][Full Text] [Related]
13. Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
Rubio MT; D'Aveni-Piney M; Labopin M; Hamladji RM; Sanz MA; Blaise D; Ozdogu H; Daguindeau E; Richard C; Santarone S; Irrera G; Yakoub-Agha I; Yeshurun M; Diez-Martin JL; Mohty M; Savani BN; Nagler A
J Hematol Oncol; 2017 Jan; 10(1):31. PubMed ID: 28118857
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
15. A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
Michelis FV; Bril V; Lipton JH
Int J Hematol; 2015 Jul; 102(1):144-6. PubMed ID: 25732066
[TBL] [Abstract][Full Text] [Related]
16. A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.
Min GJ; Park S; Park SS; Yoon JH; Lee SE; Cho BS; Eom KS; Lee S; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Kim YJ
Int J Hematol; 2019 Nov; 110(5):635-639. PubMed ID: 31309419
[TBL] [Abstract][Full Text] [Related]
17. High Incidences of Acute and Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplants for Acute Myeloid Leukemia Using Thiotepa, Busulfan, and Fludarabine Pretransplant Conditioning.
Halahleh KA; Ma'koseh M; Sultan I; Rimawi DH; Muradi I; Gale RP
Acta Haematol; 2023; 146(1):88-91. PubMed ID: 36446340
[No Abstract] [Full Text] [Related]
18. [Clinical Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of 12 Patients with Acute Leukemia in Tropical Area].
Zheng WS; Guan LX; Cheng LC; Xu YY; Shi LH; Sun D; Bo J; Wang QS; Gao XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):742-747. PubMed ID: 32552930
[TBL] [Abstract][Full Text] [Related]
19. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].
Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY
Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329
[No Abstract] [Full Text] [Related]
20. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study.
Çiftçiler R; Göker H; Demiroğlu H; Aladağ E; Aksu S; Haznedaroğlu İC; Sayınalp N; Özcebe O; Tekin F; Büyükaşık Y
Turk J Haematol; 2019 May; 36(2):88-96. PubMed ID: 30717586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
